Marchex, Inc.
NASDAQ:MCHXAdvertising Agencies
+$0.03 today
- Market cap
- $51.59M
- Beta
- 1.89
- P/E (TTM)
- -13.4
- EPS (TTM)
- -$0.11
Volume 0.02M
Average 0.02M
MCHX Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Marchex, Inc.NASDAQ: MCHX
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue declines year over year
Q1 FY2026 cost of revenue of $4.12M fell 1.6% year over year, ahead of the -2.7% change in trailing-twelve-month cost of revenue. Sequentially, it fell 2.2% from the prior quarter. Over 3 fiscal years it compounded at -6.5% a year.
Context
- Cost of revenue amounted to 36.8% of revenue in FY2025, up 1.1 pp from a year earlier.
- Cost of revenue increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of -1.6% holds above the trailing-twelve-month pace of -2.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 16.72M USD
- Year-over-year change
- -2.7%
- 4-year CAGR
- -6.3%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 16.72M | -2.7% |
| FY2024 | 2024-12-31 | 17.17M | -16.6% |
| FY2023 | 2023-12-31 | 20.58M | +0.6% |
| FY2022 | 2022-12-31 | 20.46M | -5.7% |
| FY2021 | 2021-12-31 | 21.69M | — |
Cost of Revenue vs competitors
How MCHX compares with its peers on the latest reported figures
- MCHX's LTM Mar 2026 cost of revenue of $16.64M is the 6th highest of the 7 companies compared; the peer median is $99.68M.
- Its year-over-year change of -2.7% is the 4th highest of 6, against a peer median of -0.3%.
- Cost of revenue amounts to 37.3% of revenue for MCHX, versus a peer median of 64.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $327.38M | +0.5% | +1.2% | 76.9% | |
| LTM Mar 2026 | $180.42M | -8.3% | +7.3% | 33.9% | |
| LTM Mar 2026 | $103.77M | — | +43.3% | 474.5% | |
| LTM Mar 2026 | $95.58M | -0.3% | +3.5% | 90.4% | |
| LTM Mar 2026 | $19.14M | +59.5% | +21.8% | 20.6% | |
| LTM Mar 2026 | $16.64M | -2.7% | -6.5% | 37.3% | |
| LTM Mar 2026 | $15.75M | -27.2% | -13.1% | 52.8% | |
| Peer median (excluding MCHX) | $99.68M | -0.3% | +5.4% | 64.9% | |
Competitors are the stored peer set for MCHX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 53.48M | 52.17M | 49.91M | 48.12M | 45.42M |
| Cost of Revenue | 21.69M | 20.46M | 20.58M | 17.17M | 16.72M |
| Gross Profit | 31.78M | 31.71M | 29.33M | 30.95M | 28.71M |
| Gross Margin | 59.4% | 60.8% | 58.8% | 64.3% | 63.2% |
| Research & Development | 16.11M | 14.36M | 15.36M | 12.41M | 9.75M |
| Selling, General & Admin | 22.84M | 23.3M | 21.62M | 22.38M | 23.33M |
| Operating Expenses | 43.58M | 39.86M | 38.97M | 35.4M | 33.08M |
| Depreciation & Amortization | 5.97M | 4.03M | 3.87M | 2.65M | 2.67M |
| EBITDA | 1.85M | (4.03M) | (5.76M) | (1.8M) | (2.48M) |
| EBITDA Margin | 3.5% | -7.7% | -11.5% | -3.7% | -5.5% |
| Operating Income | (11.8M) | (8.15M) | (9.64M) | (4.45M) | (4.37M) |
| Operating Margin | -22.1% | -15.6% | -19.3% | -9.2% | -9.6% |
| Interest Income | 3K | 99K | 319K | 0 | 0 |
| Interest Expense | 37K | 0 | 293K | 120K | 0 |
| Other Income / Expenses | 7.64M | 88K | (173K) | (120K) | (782K) |
| Income Before Tax | (4.16M) | (8.06M) | (9.82M) | (4.57M) | (5.16M) |
| Pre-Tax Margin | -7.8% | -15.5% | -19.7% | -9.5% | -11.4% |
| Income Tax Expense | 232K | 184K | 94K | 380K | 79K |
| Net Income | (4.39M) | (8.25M) | (9.91M) | (4.95M) | (5.24M) |
| Net Margin | -8.2% | -15.8% | -19.9% | -10.3% | -11.5% |
| EPS (Basic) | (0.10) | (0.19) | (0.23) | (0.11) | (0.12) |
| EPS (Diluted) | (0.10) | (0.19) | (0.23) | (0.11) | (0.11) |
| Weighted Avg Shares | 43.92M | 43.22M | 42.62M | 43.16M | 43.9M |
| Weighted Avg Shares (Diluted) | 43.92M | 43.22M | 42.62M | 43.16M | 48.56M |
Marchex, Inc.
NASDAQ:MCHX
Intrinsic Alpha fair value
Locked
Current Price
$1.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.